3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Breast Neoplasms
87
Carcinoma, Non-Small-Cell Lung
78
Multiple Myeloma
72
Prostatic Neoplasms
66
Neoplasms
47
Lymphoma
43
Leukemia, Myeloid, Acute
42
Melanoma
38
Neoplasm Metastasis
37
Lymphoma, Non-Hodgkin
33
Ovarian Neoplasms
32
Lung Neoplasms
32
Squamous Cell Carcinoma of Head and Neck
31
Hematologic Neoplasms
29
Leukemia, Lymphocytic, Chronic, B-Cell
28
Colorectal Neoplasms
26
Triple Negative Breast Neoplasms
23
Hodgkin Disease
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Myelodysplastic Syndromes
21
Sarcoma
20
Fallopian Tube Neoplasms
20
Pancreatic Neoplasms
19
Carcinoma, Renal Cell
19
Lymphoma, Follicular
17
Leukemia
17
Head and Neck Neoplasms
17
Glioma
17
Urinary Bladder Neoplasms
16
Recurrence
16
Interventions
pembrolizumab
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Immunoproliferative Disorders
×
90 days
×
Clear all
NCT03349450
2026-05-06
SPiReL
Sunnybrook Health Sciences Centre
Phase 2
Completed
25 enrolled
18 charts